Health Trials

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

ConditionsRectal AdenocarcinomaStage I Rectal Cancer AJCC v8Stage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8Stage IV Rectal Cancer AJCC v8Stage IVA Rectal Cancer AJCC v8Stage IVB Rectal Cancer AJCC v8Stage IVC Rectal Cancer AJCC v8
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

Eligibility criteria

Qualifiers

Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment

Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English

Disqualifiers

Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer

Patient has a concurrent cancer diagnosis at the time of consent

Patient has recurrent disease

Trial design

Treatments tested in this trial

  • Quality-of-Life Assessment
  • Questionnaire Administration

Treatment groups

430 Participants
are divided into 1 treatment group

Locations

1
M D Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov